期刊
CHEST
卷 120, 期 1, 页码 313-316出版社
AMER COLL CHEST PHYSICIANS
DOI: 10.1378/chest.120.1.313
关键词
Parkinson's disease; pergolide; pleuropulmonary fibrosis; restless legs syndrome
Pergolide is an ergot-derived dopamine agonist used in Parkinson's disease and, increasingly, in restless legs syndrome. We report a patient with a 2.5-year history of weight loss, pleuropulmonary fibrosis, and exudative pleural effusion that developed insidiously while taking this medication. The extensive and invasive workup that preceded the diagnosis highlights the difficulty in attributing such a process to a drug reaction. This is the second report of such a reaction to pergolide, which is one of the increasing number of ergot-derived compounds in common clinical use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据